SIGNALING PATHWAYS: A KEY TO UNLOCKING NEW TREATMENTS FOR SJÖGREN'S SYNDROME
This paper advocates for a multi-target therapeutic approach in SS, aiming to mitigate the intricate cytokine network and restore glandular function, ultimately improving patient outcomes.